Sawada Atsushi, Yamakage Michiaki
Department of Anesthesiology, Sapporo Medical University School of Medicine, South 1 West 16 Chuo-ku, 060-8543, Sapporo, Japan.
JA Clin Rep. 2025 Jul 29;11(1):42. doi: 10.1186/s40981-025-00807-7.
These case reports focus on successful pain management with ultrasound-guided serratus posterior superior muscle (SPSM) block using 30 mL of 0.25% ropivacaine or physiological saline in three myofascial pain syndrome (MPS) patients presented with cervicoscapular pain.
The SPSM block was administered to three ambulatory patients (cases #1, #2, and #3) who presented with cervicoscapular pain. The SPSM block with 30 mL of 0.25% ropivacaine drastically decreased an NRS score and provided 2-3 weeks of pain relief in cases #1 and #2. On the contrary, the SPSM block with 30 mL of physiological saline also mildly decreased an NRS score and provided 3 weeks of pain relief in cases #1 and #3.
The SPSM block using 30 mL of 0.25% ropivacaine or physiological saline successfully decreased the NRS scores in three MPS patients. These findings suggest that the SPSM block may serve as a useful therapeutic option in MPS patients presenting with cervicoscapular pain.
这些病例报告聚焦于对3例表现为颈肩痛的肌筋膜疼痛综合征(MPS)患者,使用30毫升0.25%罗哌卡因或生理盐水进行超声引导下的后上锯肌(SPSM)阻滞,以实现成功的疼痛管理。
对3例表现为颈肩痛的门诊患者(病例#1、#2和#3)实施了SPSM阻滞。在病例#1和#2中,使用30毫升0.25%罗哌卡因进行的SPSM阻滞显著降低了数字疼痛评分量表(NRS)评分,并提供了2至3周的疼痛缓解。相反,在病例#1和#3中,使用30毫升生理盐水进行的SPSM阻滞也轻微降低了NRS评分,并提供了3周的疼痛缓解。
使用30毫升0.25%罗哌卡因或生理盐水进行的SPSM阻滞成功降低了3例MPS患者的NRS评分。这些发现表明,SPSM阻滞可能是表现为颈肩痛的MPS患者的一种有用的治疗选择。